The invention belongs to the field of biological
medicine, and provides an
active compound for treating prostatic
cancer and a preparation method thereof. A-B-C-D-P five-module linear
connection design is adopted, wherein the A module is a
prostate specific
membrane antigen targeting binding unit, the B module is a
prostate specific
antigen enzyme digestion recognition sequence HSSKLQ, the C module is a
cathepsin B-responsive Val-Cit-p-aminobenzyl self-destruction unit, the D module is a reduction-responsive
disulfide bond connecting arm, and the P is an anti-tumor pharmacodynamic fragment. A
coupling reaction is accurately controlled through a
continuous flow microchannel technology, controllable self-
assembly of the 20-60-nanometer nano aggregate is achieved, the average hydration
diameter dispersion coefficient is not larger than 0.20, and the nano aggregate stably exists in
plasma and selectively releases drugs in a
tumor microenvironment. Multiple contradictions among
prodrug system process manufacturability,
intracellular response release and stable dispersion of the preparation are solved, and wide clinical application value is achieved.